Your browser doesn't support javascript.
loading
Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
Gruber, Michaela; Bozic, Ivana; Leshchiner, Ignaty; Livitz, Dimitri; Stevenson, Kristen; Rassenti, Laura; Rosebrock, Daniel; Taylor-Weiner, Amaro; Olive, Oriol; Goyetche, Reaha; Fernandes, Stacey M; Sun, Jing; Stewart, Chip; Wong, Alicia; Cibulskis, Carrie; Zhang, Wandi; Reiter, Johannes G; Gerold, Jeffrey M; Gribben, John G; Rai, Kanti R; Keating, Michael J; Brown, Jennifer R; Neuberg, Donna; Kipps, Thomas J; Nowak, Martin A; Getz, Gad; Wu, Catherine J.
Afiliação
  • Gruber M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bozic I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Leshchiner I; Department of Internal Medicine I, Division of Haematology and Haemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Livitz D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Stevenson K; Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
  • Rassenti L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Taylor-Weiner A; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Olive O; Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA.
  • Goyetche R; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fernandes SM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stewart C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wong A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cibulskis C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhang W; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Reiter JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gerold JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gribben JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rai KR; Program for Evolutionary Dynamics, Harvard University, Cambridge, MA, USA.
  • Keating MJ; Program for Evolutionary Dynamics, Harvard University, Cambridge, MA, USA.
  • Brown JR; Barts Cancer Institute, Queen Mary, University of London, London, UK.
  • Neuberg D; Hofstra North Shore-LIJ School of Medicine, Lake Success, NY, USA.
  • Kipps TJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
  • Nowak MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Getz G; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Wu CJ; Harvard Medical School, Boston, MA, USA.
Nature ; 570(7762): 474-479, 2019 06.
Article em En | MEDLINE | ID: mdl-31142838
ABSTRACT
How the genomic features of a patient's cancer relate to individual disease kinetics remains poorly understood. Here we used the indolent growth dynamics of chronic lymphocytic leukaemia (CLL) to analyse the growth rates and corresponding genomic patterns of leukaemia cells from 107 patients with CLL, spanning decades-long disease courses. We found that CLL commonly demonstrates not only exponential expansion but also logistic growth, which is sigmoidal and reaches a certain steady-state level. Each growth pattern was associated with marked differences in genetic composition, the pace of disease progression and the extent of clonal evolution. In a subset of patients, whose serial samples underwent next-generation sequencing, we found that dynamic changes in the disease course of CLL were shaped by the genetic events that were already present in the early slow-growing stages. Finally, by analysing the growth rates of subclones compared with their parental clones, we quantified the growth advantage conferred by putative CLL drivers in vivo.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Evolução Molecular Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Evolução Molecular Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
...